Current approach to hemochromatosis

Blood Reviews - Tập 22 - Trang 195-210 - 2008
Pierre Brissot1, Marie-Bérengère Troadec1, Edouard Bardou-Jacquet1, Caroline Le Lan1, Anne-Marie Jouanolle1,2, Yves Deugnier1, Olivier Loréal1
1Liver Disease Unit, Liver Research Unit Inserm U-522, IFR 140, University of Rennes1, Hemochromatosis Reference Center, France
2Laboratory of Molecular Genetics, University Hospital Pontchaillou, Rennes, France

Tài liệu tham khảo

Feder, 1996, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat Genet, 13, 399, 10.1038/ng0896-399

Brissot, 2004, The clinical relevance of new insights in iron transport and metabolism, Curr Hematol Rep, 3, 107

Loreal, 2005, Hepcidin in iron metabolism, Curr Protein Pept Sci, 6, 279, 10.2174/1389203054065392

Camaschella, 2005, Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders, Blood, 106, 3710, 10.1182/blood-2005-05-1857

Deugnier Y, Brissot P, Loréal O. Iron and the Liver: Update 2008. J Hepatol 2008:in press.

OMIM. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=omim.

Brissot P, Le Lan C, Troadec MB, et al.: Diagnosis and Treatment of HFE-haemochromatosis. In: Handbook ESoH, ed. Disorders of Iron homeostasis, Erythrocytes, Erythropoiesis, 2006.

Pietrangelo, 2007, Hemochromatosis: an endocrine liver disease, Hepatology, 46, 1291, 10.1002/hep.21886

Merryweather-Clarke, 1997, Global prevalence of putative haemochromatosis mutations, J Med Genet, 34, 275, 10.1136/jmg.34.4.275

Poddar, 2006, Hereditary hemochromatosis-Special reference to Indian scenario, Int J Human Genet, 6, 73, 10.1080/09723757.2006.11885947

Dhillon, 2007, Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India, World J Gastroenterol, 13, 2956, 10.3748/wjg.v13.i21.2956

Waalen, 2005, The penetrance of hereditary hemochromatosis, Best Pract Res Clin Haematol, 18, 203, 10.1016/j.beha.2004.08.023

Beutler, 2002, Penetrance of 845G–> A (C282Y) HFE hereditary haemochromatosis mutation in the USA, Lancet, 359, 211, 10.1016/S0140-6736(02)07447-0

Adams, 2005, Hemochromatosis and iron-overload screening in a racially diverse population, N Engl J Med, 352, 1769, 10.1056/NEJMoa041534

Powell, 2006, Screening for hemochromatosis in asymptomatic subjects with or without a family history, Arch Intern Med, 166, 294, 10.1001/archinte.166.3.294

Asberg, 2007, Prevalence of liver fibrosis and cirrhosis in screening-detected C282Y homozygous subjects, Scand J Gastroenterol, 42, 782, 10.1080/00365520601076058

van der, 2006, HFE genotypes and dietary heme iron: no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women, Nutr Metab Cardiovasc Dis, 16, 60, 10.1016/j.numecd.2005.07.008

Cade, 2005, Diet and genetic factors associated with iron status in middle-aged women, Am J Clin Nutr, 82, 813, 10.1093/ajcn/82.4.813

Kaltwasser, 1998, Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis, Gut, 43, 699, 10.1136/gut.43.5.699

Barton, 2001, Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis, Transfusion, 41, 123, 10.1046/j.1537-2995.2001.41010123.x

Distante, 2000, HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis, Gut, 47, 575, 10.1136/gut.47.4.575

Beutler, 2005, Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype, Blood Cells Mol Dis, 35, 326, 10.1016/j.bcmd.2005.08.003

Beutler, 2006, Helicobacter pylori infection and HFE hemochromatosis, Blood Cells Mol Dis, 37, 188, 10.1016/j.bcmd.2006.08.002

Detivaud, 2005, Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function, Blood, 106, 746, 10.1182/blood-2004-12-4855

Bridle, 2006, Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease, Alcohol Clin Exp Res, 30, 106, 10.1111/j.1530-0277.2006.00002.x

Harrison-Findik, 2006, Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression, J Biol Chem, 281, 22974, 10.1074/jbc.M602098200

Laine, 2005, Phenotypic expression in detected C282Y homozygous women depends on body mass index, J Hepatol, 43, 1055, 10.1016/j.jhep.2005.05.027

Bekri, 2006, Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH, Gastroenterology, 131, 788, 10.1053/j.gastro.2006.07.007

Hutchinson, 2007, Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis, Gut, 56, 1291, 10.1136/gut.2006.108613

Moirand, 1997, Clinical features of genetic hemochromatosis in women compared with men, Ann Intern Med, 127, 105, 10.7326/0003-4819-127-2-199707150-00002

Deugnier, 2002, Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 french people, Br J Haematol, 118, 1170, 10.1046/j.1365-2141.2002.03718.x

Olynyk, 1999, A population-based study of the clinical expression of the hemochromatosis gene, N Engl J Med, 341, 718, 10.1056/NEJM199909023411002

Asberg, 2001, Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons, Scand J Gastroenterol, 36, 1108, 10.1080/003655201750422747

Levy, 2000, Genes that modify the hemochromatosis phenotype in mice, J Clin Invest, 105, 1209, 10.1172/JCI9635

Bensaid, 2004, Multigenic control of hepatic iron loading in a murine model of hemochromatosis, Gastroenterology, 126, 1400, 10.1053/j.gastro.2004.01.021

Tolosano, 2005, Haptoglobin modifies the hemochromatosis phenotype in mice, Blood, 105, 3353, 10.1182/blood-2004-07-2814

Jacolot, 2004, HAMP as a modifier gene that increase the phenotypic expression of the HFE C282Y homozygous genotype, Blood, 103, 2340, 10.1182/blood-2003-10-3366

Merryweather-Clarke, 2003, Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis, Hum Mol Genet, 12, 2241, 10.1093/hmg/ddg225

Le Gac, 2004, The recently identifiedtype 2A juvenile haemochromatosis gene (HJV), a seconf candidate modifier of the C282Y homozygous phenotype, Hum Mol Genet, 13, 1913, 10.1093/hmg/ddh206

Millet, 2007, Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway module HFE hemochromatosis penetrance, Am J Human Genet, 81, 799, 10.1086/520001

Lee, 2002, Seeking candidate mutations that affect iron homeostasis, Blood Cells Mol Dis, 29, 471, 10.1006/bcmd.2002.0586

Carter, 2003, Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis, Br J Haematol, 122, 326, 10.1046/j.1365-2141.2003.04436.x

Kelleher, 2004, DMT1 genetic variability is not responsible for phenotype variability in hereditary hemochromatosis, Blood Cells Mol Dis, 33, 35, 10.1016/j.bcmd.2004.04.005

Gochee, 2002, A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation, Gastroenterology, 122, 646, 10.1016/S0016-5085(02)80116-0

Walsh, 2006, The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis, Clin Gastroenterol Hepatol, 4, 1403, 10.1016/j.cgh.2006.07.009

Papanikolaou, 2004, Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis, Nat Genet, 36, 77, 10.1038/ng1274

Roetto, 2003, Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis, Nat Genet, 33, 21, 10.1038/ng1053

Roetto, 2001, New mutations inactivating transferrin receptor 2 in hemochromatosis type 3, Blood, 97, 2555, 10.1182/blood.V97.9.2555

Girelli, 2002, Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene, Gastroenterology, 122, 1295, 10.1053/gast.2002.32984

Majore, 2006, Homozygous p.M172K mutation of the TFR2 gene in an Italian family with type 3 hereditary hemochromatosis and early onset iron overload, Haematologica, 91, ECR33

Pietrangelo, 2004, The ferroportin disease, Blood Cells Mol Dis, 32, 131, 10.1016/j.bcmd.2003.08.003

Wallace, 2007, Non-HFE haemochromatosis, World J Gastroenterol, 13, 4690, 10.3748/wjg.v13.i35.4690

Montosi, 2001, Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene, J Clin Invest, 108, 619, 10.1172/JCI200113468

Njajou, 2001, A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis, Nat Genet, 28, 213, 10.1038/90038

Barton, 2007, SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent, Blood Cells Mol Dis, 39, 206, 10.1016/j.bcmd.2007.03.008

Beutler, 2003, Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans, Blood Cells Mol Dis, 31, 305, 10.1016/S1079-9796(03)00165-7

Rivers, 2007, Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study, Blood Cells Mol Dis, 38, 247, 10.1016/j.bcmd.2006.12.002

Subramaniam, 2005, Ferroportin disease due to the A77D mutation in Australia, Gut, 54, 1048, 10.1136/gut.2005.069021

Koyama, 2005, A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron, Intern Med, 44, 990, 10.2169/internalmedicine.44.990

Hsiao, 2007, A novel mutation of transferrin receptor 2 in a Taiwanese woman with type 3 hemochromatosis, J Hepatol, 47, 303, 10.1016/j.jhep.2007.04.014

Agarwal, 2006, Ferroportin (SLC40A1) gene in thalassemic patients of Indian descent, Clin Genet, 70, 86, 10.1111/j.1399-0004.2006.00644.x

Wallace, 2004, Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis, J Hepatol, 40, 710, 10.1016/j.jhep.2003.12.008

Sham, 2005, Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features, Blood Cells Mol Dis, 34, 157, 10.1016/j.bcmd.2004.12.002

Miyajima, 2003, Aceruloplasminemia, an inherited disorder of iron metabolism, Biometals, 16, 205, 10.1023/A:1020775101654

Yoshida, 1995, A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans, Nat Genet, 9, 267, 10.1038/ng0395-267

Kono, 2006, Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia, Gastroenterology, 131, 240, 10.1053/j.gastro.2006.04.017

Knisely, 2004, Molecular characterization of a third case of human atransferrinemia, Blood, 104, 2607, 10.1182/blood-2004-05-1751

Mims, 2005, Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload, Blood, 105, 1337, 10.1182/blood-2004-07-2966

Beaumont, 2006, Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload, Blood, 107, 4168, 10.1182/blood-2005-10-4269

Iolascon, 2006, Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2), Blood, 107, 349, 10.1182/blood-2005-06-2477

Camaschella, 2007, The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload, Blood, 110, 1353, 10.1182/blood-2007-02-072520

Krause, 2000, LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity, FEBS Lett, 480, 147, 10.1016/S0014-5793(00)01920-7

Park, 2001, Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J Biol Chem, 276, 7806, 10.1074/jbc.M008922200

Pigeon, 2001, A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload, J Biol Chem, 276, 7811, 10.1074/jbc.M008923200

Peyssonnaux, 2006, TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens, Blood, 107, 3727, 10.1182/blood-2005-06-2259

Nemeth, 2003, Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein, Blood, 101, 2461, 10.1182/blood-2002-10-3235

Nicolas, 2002, Hepcidin, A New Iron Regulatory Peptide, Blood Cells Mol Dis, 29, 327, 10.1006/bcmd.2002.0573

Ganz, 2007, Molecular control of iron transport, J Am Soc Nephrol, 18, 394, 10.1681/ASN.2006070802

Andrews, 2006, Iron homeostasis, Annu. Rev. Physiol., 69, 16.11

Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742

Rivera, 2005, Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs, Blood, 2196, 10.1182/blood-2005-04-1766

Courselaud, 2002, C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism, J Biol Chem, 277, 41163, 10.1074/jbc.M202653200

Babitt, 2006, Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression, Nat Genet, 38, 531, 10.1038/ng1777

Wang, 2005, A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression, Cell Metab, 2, 399, 10.1016/j.cmet.2005.10.010

Truksa J, Peng H, Lee P, Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin1 expression independently of Hfe, transferrin receptor 2. Proc Natl Acad Sci U S A 2006:10289–10293.

Goswami, 2006, Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing, J Biol Chem, 281, 28494, 10.1074/jbc.C600197200

Calzolari, 2006, TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway, J Cell Sci, 119, 4486, 10.1242/jcs.03228

Silvestri, 2007, Furin mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis, Blood

Valore, 2008, Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin, Blood Cells Mol Dis, 40, 132, 10.1016/j.bcmd.2007.07.009

Nicolas, 2001, Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice, Proc Natl Acad Sci USA, 98, 8780, 10.1073/pnas.151179498

Papanikolaou, 2005, Hepcidin in iron overload disorders, Blood, 105, 4103, 10.1182/blood-2004-12-4844

Hershko, 1978, Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity, Br J Haematol, 40, 255, 10.1111/j.1365-2141.1978.tb03662.x

Hider, 2002, Nature of nontransferrin-bound iron, Eur J Clin Invest, 32, 50, 10.1046/j.1365-2362.2002.0320s1050.x

Brissot, 1985, Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states, J Clin Invest, 76, 1463, 10.1172/JCI112125

Esposito, 2003, Labile plasma iron in iron overload: redox activity and susceptibility to chelation, Blood, 102, 2670, 10.1182/blood-2003-03-0807

Le Lan, 2005, Redox active plasma iron in C282Y/C282Y hemochromatosis, Blood, 105, 4527, 10.1182/blood-2004-09-3468

Drakesmith, 2005, Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin, Blood, 106, 1092, 10.1182/blood-2005-02-0561

De Domenico, 2006, Iron overload due to mutations in ferroportin, Haematologica, 91, 92

De Domenico, 2007, Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin, Embo J, 26, 2823, 10.1038/sj.emboj.7601735

Moirand, 1995, Regulation of ferritin expression by alcohol in a human hepatoblastoma cell line and in rat hepatocyte cultures, J Hepatol, 23, 431, 10.1016/0168-8278(95)80202-9

Mendler, 1999, Insulin resistance-associated hepatic iron overload, Gastroenterology, 117, 1155, 10.1016/S0016-5085(99)70401-4

Loreal O, Nemeth E, Le Lan C, et al. Abnormal expression of hepcidin during genetic hemochromatosis, alcoholic cirrhosis,and dysmetabolic hepatosiderosis-Abstract. International Bio-Iron Society.Kyoto.April, 1–6,2007. Am J Hematol 2008;in press.

Ferrante, 2005, Hereditary hyperferritinaemia-cataract syndrome: a challenging diagnosis for the hepatogastroenterologist, Eur J Gastroenterol Hepatol, 17, 1247, 10.1097/00042737-200511000-00016

Pinto, 2007, Macrophage activation syndrome: experience from a tertiary referral centre, J Assoc Physicians India, 55, 185

Gandon, 2004, Non-invasive assessment of hepatic iron stores by MRI, Lancet, 33, 338

St Pierre, 2005, Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance, Blood, 105, 855, 10.1182/blood-2004-01-0177

Pietrangelo, 2004, Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease, Blood Cells Mol Dis, 37, 192, 10.1016/j.bcmd.2006.08.007

Deugnier, 2007, Pathology of hepatic iron overload, World J Gastroenterol, 13, 4755, 10.3748/wjg.v13.i35.4755

Sebastiani, 2006, Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy, World J Gastroenterol, 12, 3682, 10.3748/wjg.v12.i23.3682

Stauber, 2007, Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C, World J Gastroenterol, 13, 4287, 10.3748/wjg.v13.i32.4287

Deugnier, 2002, Increased body iron stores in elite road cyclists, Med Sci Sports Exerc, 34, 876, 10.1097/00005768-200205000-00023

Tanno, 2007, High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin, Nat Med, 13, 1096, 10.1038/nm1629

Piperno, 2007, Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis, Blood, 110, 4096, 10.1182/blood-2007-06-096503

Piperno, 2004, Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload, Haematologica, 89, 359

Le Gac, 2004, Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent, Br J Haematol, 125, 674, 10.1111/j.1365-2141.2004.04950.x

HAS. French recommendations for management of HFE hemochromatosis. Haute Autorité de Santé 2005; www.has-sante.fr.

Brissot, 2006, Current approaches to the management of hemochromatosis, Hematology Am Soc Hematol Educ Program, 36, 10.1182/asheducation-2006.1.36

Loreal, 2002, Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights, J Hepatol, 36, 851, 10.1016/S0168-8278(02)00042-9

Roberts DJ, Brunskill SJ, Doree C, Williams S, Howard J, Hyde CJ. Oral deferiprone for iron chelation in people with thalassaemia. Cochrane Database Syst Rev 2007:CD004839.

Henter, 2007, Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia, Blood, 109, 5157, 10.1182/blood-2007-02-065805

Cappellini, 2006, A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia, Blood, 107, 3455, 10.1182/blood-2005-08-3430

Adams, 2007, Biological variability of transferrin saturation and unsaturated iron-binding capacity, Am J Med, 120, 10.1016/j.amjmed.2007.02.027

Waalen, 2007, Screening for hemochromatosis by measuring ferritin levels: a more effective approach, Blood, 10.1182/blood.V110.11.2673.2673

Thông tin
Thông tin xuất bản

Blood Reviews

Tập 22

195-210

Thông tin tác giả